ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Takeda Completes Acquisition of ARIAD Pharmaceuticals
americanpharmaceuticalreview
February 20, 2017Takeda Pharmaceutical Company has announced the completion of its acquisition of ARIAD Pharmaceuticals, Inc. for $24.00 per share in cash. -
Takeda to Acquire ARIAD Pharmaceuticals
americanpharmaceuticalreview
January 11, 2017Takeda Pharmaceutical Company Limited and ARIAD Pharmaceuticals have entered into a definitive agreement under which Takeda will acquire all of the outstanding shares in ARIAD for $24.00 per share in cash, or an enterprise value of approximately $5.2 bill
Pharma Sources Insight January 2025
